Research.Patient.info
borderline personality disorder research hub
2 indexed studies · 0 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
Ketamine infusion for symptomatological improvement of severe borderline personality disorder: a pilot study
This study is looking at whether a specific dose of ketamine, delivered as an infusion, can help improve severe symptoms in adults with Borderline Personality Disorder (BPD). It's a small, early-stage study to see if this treatment might be helpful.
France - authorisedTherapeutic exploratory (Phase II)
A phase II, double-blinded, placebo-controlled, clinical trial to determine the efficacy and safety of AP707 in the treatment of Borderline Personality Disorder.
This study is testing a new medication called AP707 for people with Borderline Personality Disorder. Researchers want to see if AP707 helps improve symptoms and if it's safe to use, compared to a dummy pill (placebo).
Germany